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CORRESPONDENCE
Letter to the Editor
Antiproliferation and Redifferentiation in Thyroid Cancer Cell 
Line by Polyphenol Phytochemicals
Tae Yong Kim  
Department of Internal Medicine, Asan Medical Center, University of College of Medicine, Seoul, Korea
I read the article “Antiproliferation and Redifferentiation in Thy-
roid Cancer Cell Line by Polyphenol Phytochemicals” in the Jour-
nal of Korean Medical Science by Kang et al. (1). I would like 
comment that some of the cell lines they used are not originat-
ed from the thyroid. 
  Stable cancer cell lines derived from human cancers are very 
useful models to predict clinical response of new therapeutics. 
Schweppe et al. (2) evaluated 40 reported thyroid cancer-derived 
cell lines using short tandem repeat and single nucleotide poly-
morphism array analysis. They found some misidentified cell 
lines. The ARO matched the HT-29 colon cancer cell line, and 
NPA matched the M14/MDA-MB-435S melanoma cell line. 
  The report of Schweppe et al. (2) was available online at Au-
gust 2008, two and half years earlier than the submission date 
of paper from Kang et al. (1). Kang et al. (1) showed that quer-
cetin did not induce NIS in ARO cell and induced NIS very slight-
ly in NPA cells. These results make sense because ARO and NPA 
cells are not originated from the thyroid. 
Careful choice of thyroid cancer cell lines with unique source is 
crucial. Ringel (3) recommended researchers to establish if the 
cell lines in their laboratories are either thyroid or unique by com-
paring them with the data in the paper by Schweppe et al. (2).  
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